Odyssey Therapeutics
PublicOdyssey Therapeutics is now publicly traded
The data on this page reflects Odyssey Therapeutics's private-market history up to the point it went public, including its funding rounds, valuation, and investors.
Went Public
Jan 17, 2025
Last Round
Series D
Sep 10, 2025
Total Funding Raised
$800M
Company Overview
Odyssey Therapeutics is a biotechnology company that develops precision immunomodulators and oncology medicines to treat autoimmune and inflammatory diseases.
Sector
Biotech
AI Layer
Application
Keywords
small molecule drug discoveryprecision medicineAI-driven drug discoverybiotechdrug discovery platformoncology pipelineimmunologycomputational chemistryin silico drug designbiopharmatherapeutic candidatesdrug developmentAI-first biotechsmall molecule inhibitorsbiotech startup
Odyssey Therapeutics Comparables
Compare Odyssey Therapeutics with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Treeline Biosciences | 89% | |
| Eikon Therapeutics | 81% | |
| Mirador Therapeutics | 80% | |
Odyssey Therapeutics Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series D | Sep 10, 2025 | ||||
| IPO | Jan 17, 2025 | ||||
| Series C | Dec 5, 2023 | ||||
| Series B | Oct 13, 2022 | ||||
| Series A | Dec 7, 2021 |
Key People
Founding team and executive leadership
Odyssey Therapeutics Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| GreatPoint Ventures | Series B |
| CPP Investments | Series C |
| Wedbush Healthcare Partners | Series D |
| KB Investment | Series C |
| Frontline BioVentures | Series B, Series C, Series A |
| KB Investment | Series C |
| Creacion Ventures | Series B, Series C, Series A, Series D |
Odyssey Therapeutics Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Firmographic Details
HeadquartersBoston, Massachusetts
Employee Range118
Year Founded2021
Last FundingSep 10, 2025